Akoya Biosciences (AKYA) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free AKYA Stock Alerts $2.05 -0.04 (-1.91%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 9:00 AM | insidertrades.comAkoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells $15,075.00 in StockJune 7 at 10:36 PM | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 SharesAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the business's stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $2.01, for a total value of $15,075.00. Following the completion of the transaction, the chief executive officer now directly owns 224,733 shares in the company, valued at approximately $451,713.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.June 3, 2024 | americanbankingnews.comAkoya Biosciences (NASDAQ:AKYA) Price Target Cut to $4.00 by Analysts at Morgan StanleyJune 3, 2024 | americanbankingnews.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Growth in Short InterestJune 1, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 11.5% in MayAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, a growth of 11.5% from the April 30th total of 1,040,000 shares. Approximately 5.3% of the company's shares are short sold. Based on an average daily volume of 276,300 shares, the days-to-cover ratio is currently 4.2 days.May 29, 2024 | finance.yahoo.comWe Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO CompensationMay 19, 2024 | msn.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Q1 2024 Earnings Call TranscriptMay 19, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Rating of "Moderate Buy" by AnalystsAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation andMay 16, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Akoya Biosciences, Inc.'s Q2 2024 Earnings (NASDAQ:AKYA)Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) - Capital One Financial reduced their Q2 2024 earnings estimates for Akoya Biosciences in a research report issued to clients and investors on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will earn ($0.2May 14, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Akoya Biosciences (AKYA)May 14, 2024 | marketbeat.comAkoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group reduced their price objective on Akoya Biosciences from $10.00 to $6.00 and set a "buy" rating for the company in a research report on Tuesday.May 14, 2024 | marketwatch.comShares of Akoya Biosciences Drop After 1Q Earnings, Revenue Outlook MissMay 14, 2024 | finance.yahoo.comAkoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...May 13, 2024 | investorplace.comAKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | globenewswire.comAkoya Biosciences Reports First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comAkoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma PatientsMay 8, 2024 | marketbeat.comPeddock Capital Advisors LLC Grows Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA)Peddock Capital Advisors LLC grew its position in Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) by 546.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 290,720 shares of the company's stock after buying an additional 245,728May 6, 2024 | globenewswire.comAkoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, MassachusettsMay 2, 2024 | globenewswire.comAkoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsApril 22, 2024 | globenewswire.comAkoya to Report First Quarter 2024 Financial Results on May 13th, 2024April 16, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 5.9% in MarchAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 988,400 shares, a decrease of 5.9% from the March 15th total of 1,050,000 shares. Based on an average daily trading volume, of 203,800 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.7% of the company's shares are sold short.April 9, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)April 6, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by Kent Lake Capital LLCKent Lake Capital LLC decreased its holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) by 84.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 116,835 shares of the company's stock after selling 629,686 shaApril 5, 2024 | globenewswire.comAkoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleMarch 22, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells $37,275.00 in StockAkoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) CEO Brian Mckelligon sold 7,500 shares of Akoya Biosciences stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $4.97, for a total value of $37,275.00. Following the sale, the chief executive officer now owns 231,868 shares in the company, valued at $1,152,383.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.March 17, 2024 | marketbeat.comShort Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 8.1%Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) saw a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 835,500 shares, an increase of 8.1% from the February 14th total of 773,200 shares. Approximately 3.9% of the company's shares are sold short. Based on an average daily trading volume, of 209,100 shares, the days-to-cover ratio is presently 4.0 days.March 16, 2024 | uk.investing.comAkoya Biosciences CEO sells $37k worth of sharesMarch 15, 2024 | insidertrades.comInsider Selling: Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells 7,500 Shares of StockMarch 9, 2024 | uk.investing.comAkoya Biosciences Inc (AKYA)March 7, 2024 | marketbeat.comAkoya Biosciences, Inc. Forecasted to Post FY2024 Earnings of ($0.90) Per Share (NASDAQ:AKYA)Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) - Research analysts at Capital One Financial increased their FY2024 earnings per share estimates for shares of Akoya Biosciences in a note issued to investors on Monday, March 4th. Capital One Financial analyst T. Chiang now expects that the comMarch 6, 2024 | seekingalpha.comAkoya Biosciences, Inc. (AKYA) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | markets.businessinsider.comMassaro Issues Buy Rating for Akoya Biosciences Amid Strong Financial Performance and Market Growth PotentialMarch 6, 2024 | marketbeat.comJPMorgan Chase & Co. Trims Akoya Biosciences (NASDAQ:AKYA) Target Price to $10.00JPMorgan Chase & Co. lowered their target price on Akoya Biosciences from $12.00 to $10.00 and set an "overweight" rating on the stock in a research note on Wednesday.March 6, 2024 | marketbeat.comCapital One Financial Weighs in on Akoya Biosciences, Inc.'s FY2025 Earnings (NASDAQ:AKYA)Akoya Biosciences, Inc. (NASDAQ:AKYA - Free Report) - Stock analysts at Capital One Financial issued their FY2025 earnings per share estimates for shares of Akoya Biosciences in a report issued on Monday, March 4th. Capital One Financial analyst T. Chiang anticipates that the company will post eaMarch 5, 2024 | finance.yahoo.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | marketbeat.comAkoya Biosciences (NASDAQ:AKYA) PT Raised to $7.50 at UBS GroupUBS Group boosted their target price on Akoya Biosciences from $7.00 to $7.50 and gave the stock a "buy" rating in a research note on Tuesday.March 5, 2024 | marketbeat.comAkoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Akoya Biosciences, Inc. (NASDAQ:AKYA - Get Free Report) have received an average rating of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy ratingMarch 5, 2024 | marketbeat.comAkoya Biosciences' (AKYA) Buy Rating Reiterated at Canaccord Genuity GroupCanaccord Genuity Group reiterated a "buy" rating and issued a $10.00 target price on shares of Akoya Biosciences in a report on Tuesday.March 5, 2024 | marketbeat.comAkoya Biosciences (NASDAQ:AKYA) Announces Quarterly Earnings ResultsAkoya Biosciences (NASDAQ:AKYA - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.05. Akoya Biosciences had a negative return on equity of 121.74% and a negative net margin of 78.14%. During the same period last year, the company posted ($0.50) earnings per share.March 5, 2024 | finanznachrichten.deAkoya Biosciences, Inc.: Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial OutlookMarch 5, 2024 | finance.yahoo.comQ4 2023 Akoya Biosciences Inc Earnings CallMarch 4, 2024 | investorplace.comAKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023March 4, 2024 | benzinga.comRecap: Akoya Biosciences Q4 EarningsMarch 4, 2024 | msn.comAkoya Biosciences GAAP EPS of -$0.22 beats by $0.06, revenue of $26.5M beats by $0.39MMarch 4, 2024 | finance.yahoo.comAkoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 OutlookMarch 4, 2024 | globenewswire.comAkoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial OutlookMarch 3, 2024 | markets.businessinsider.comAkoya Biosciences earnings: here's what to expectMarch 1, 2024 | benzinga.comEarnings Outlook For Akoya BiosciencesFebruary 24, 2024 | finance.yahoo.comAkoya Biosciences Insiders Placed Bullish Bets Worth US$2.11mFebruary 22, 2024 | benzinga.comAkoya Biosciences Stock (NASDAQ:AKYA) Insider Trades Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution AKYA Media Mentions By Week AKYA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKYA News Sentiment▼0.470.77▲Average Medical News Sentiment AKYA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKYA Articles This Week▼52▲AKYA Articles Average Week Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATHA News Today PRLD News Today NAUT News Today HBIO News Today SEER News Today BNGO News Today PRE News Today RPID News Today AXDX News Today OMIC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKYA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | Sponsored